Figure 2. GVHD-related histopathological examinationof groups. a, b, c: Hepatic pathology of GVHD (a: healthycontrol, 50x; b: BMT-control-GVHD, 100x; c: BMT-control-GVHD, 200x). d, e, f: Intestinal pathology of GVHD (d:healthy control, 50x; e: BMT-control-GVHD, 25x; f: BMTcontrol-GVHD, 200x); g, h, i: Dermatological pathologyof GVHD (g: healthy control, 50x; h: BMT-control-GVHD,100x; i: BMT-control-GVHD, 200x).
